From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis
Characteristics | Total(N) | Odds Ratio(OR) | P value |
---|---|---|---|
Age (> 60 vs. <  = 60) | 1,083 | 1.211 (0.953–1.540) | 0.118 |
T stage (T3&T4 vs. T1&T2) | 1,080 | 1.322 (0.955–1.836) | 0.093 |
N stage (N1&N2&N3 vs. N0) | 1,064 | 1.427 (1.121–1.818) | 0.004 |
M stage (M1 vs. M0) | 922 | 1.625 (0.666–4.182) | 0.293 |
Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 1,060 | 1.516 (1.144–2.014) | 0.004 |
ER status (Positive vs. Negative) | 1,033 | 4.950 (3.561–6.982) |  < 0.001 |
PR status (Positive vs. Negative) | 1,030 | 2.639 (2.019–3.464) |  < 0.001 |
HER2 status (Positive vs. Negative) | 715 | 1.136 (0.797–1.620) | 0.480 |
radiation_therapy (Yes vs. No) | 987 | 1.171 (0.910–1.506) | 0.219 |